| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AAV9-mediated SH3TC2 gene replacement therapy targeted to Schwann cells for the treatment of CMT4C
|
Georgiou, Elena
|
|
|
31 |
11 |
p. 3290-3307
|
artikel
|
| 2 |
Advancing cell and gene therapies: Key takeaways from ASGCT’s 5th Annual Policy Summit
|
Drago, Daniela
|
|
|
31 |
11 |
p. 3121-3122
|
artikel
|
| 3 |
A new advanced stem cell-based embryonic model: The ultimate model?
|
Declercq, S.
|
|
|
31 |
11 |
p. 3109-3110
|
artikel
|
| 4 |
Arming CAR-T cells with cytokines and more: Innovations in the fourth-generation CAR-T development
|
Tang, Lin
|
|
|
31 |
11 |
p. 3146-3162
|
artikel
|
| 5 |
Asparagine endopeptidase protects podocytes in adriamycin-induced nephropathy by regulating actin dynamics through cleaving transgelin
|
Qiu, Yang
|
|
|
31 |
11 |
p. 3337-3354
|
artikel
|
| 6 |
CXCR4-modified CAR-T cells suppresses MDSCs recruitment via STAT3/NF-κB/SDF-1α axis to enhance efficacy against pancreatic cancer
|
Sun, Ruixin
|
|
|
31 |
11 |
p. 3193-3209
|
artikel
|
| 7 |
Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants
|
Sun, Cheng-Pu
|
|
|
31 |
11 |
p. 3322-3336
|
artikel
|
| 8 |
Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington’s disease
|
O’Reilly, Daniel
|
|
|
31 |
11 |
p. 3355-3356
|
artikel
|
| 9 |
Human macrophage migration inhibitory factor potentiates mesenchymal stromal cell efficacy in a clinically relevant model of allergic asthma
|
Hawthorne, Ian J.
|
|
|
31 |
11 |
p. 3243-3258
|
artikel
|
| 10 |
Inhibiting post-translational methylation to prevent GVHD
|
Mavers, Melissa
|
|
|
31 |
11 |
p. 3115-3116
|
artikel
|
| 11 |
In this issue
|
|
|
|
31 |
11 |
p. 3111
|
artikel
|
| 12 |
Intrathecal delivery of AAV-NDNF ameliorates disease progression of ALS mice
|
Cheng, Wei
|
|
|
31 |
11 |
p. 3277-3289
|
artikel
|
| 13 |
In vivo CRISPR gene editing in patients with herpetic stromal keratitis
|
Wei, Anji
|
|
|
31 |
11 |
p. 3163-3175
|
artikel
|
| 14 |
Lethal immunotoxicity in high-dose systemic AAV therapy
|
Duan, Dongsheng
|
|
|
31 |
11 |
p. 3123-3126
|
artikel
|
| 15 |
Macrophages, MIFs, and MSCs: Defining an MOA in murine experimental asthma
|
Galipeau, Jacques
|
|
|
31 |
11 |
p. 3117-3118
|
artikel
|
| 16 |
METTL5-mediated 18S rRNA m6A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression
|
Dai, Zihao
|
|
|
31 |
11 |
p. 3225-3242
|
artikel
|
| 17 |
Oncolytic virus and inhibitor for NEDD8-activating enzyme pevonedistat: Promising combination for cancer therapy?
|
Guo, Zong Sheng
|
|
|
31 |
11 |
p. 3112-3114
|
artikel
|
| 18 |
Optimal delivery of RNA interference by viral vectors for cancer therapy
|
Wong, Boaz
|
|
|
31 |
11 |
p. 3127-3145
|
artikel
|
| 19 |
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy
|
Wong, Boaz
|
|
|
31 |
11 |
p. 3176-3192
|
artikel
|
| 20 |
Preclinical evaluation of KH631, a novel rAAV8 gene therapy product for neovascular age-related macular degeneration
|
Ke, Xiao
|
|
|
31 |
11 |
p. 3308-3321
|
artikel
|
| 21 |
Refining chimeric antigen receptors via barcoded protein domain combination pooled screening
|
Rios, Xavier
|
|
|
31 |
11 |
p. 3210-3224
|
artikel
|
| 22 |
Regulatory approval of islet transplantation for treatment of type 1 diabetes: Implications and what is on the horizon
|
Stabler, Cherie L.
|
|
|
31 |
11 |
p. 3107-3108
|
artikel
|
| 23 |
Sweeten the deal: Glycopolymer-based engineering to modulate autoreactive T cell responses
|
Markusic, David M.
|
|
|
31 |
11 |
p. 3119-3120
|
artikel
|
| 24 |
Targeting PRMT1 prevents acute and chronic graft-versus-host disease
|
Zhao, Xiaoyan
|
|
|
31 |
11 |
p. 3259-3276
|
artikel
|
| 25 |
The Nobel Prize awarded to pioneers of mRNA vaccines
|
Herzog, Roland W.
|
|
|
31 |
11 |
p. 3105-3106
|
artikel
|
Tijdschrift beschrijving